shutterstock_690219232
Katherine Welles / Shutterstock.com
11 March 2019Big Pharma

Merck partners with King’s College London to develop painkillers

King’s College London (KCL) has entered a licensing and collaboration agreement with US pharmaceutical company Merck & Co to develop new chronic pain medications.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
28 January 2019   German pharmaceutical company Merck Group has granted US biotech firm Vertex a licence to two DNA-dependent protein kinases inhibitors.

More on this story

Americas
28 January 2019   German pharmaceutical company Merck Group has granted US biotech firm Vertex a licence to two DNA-dependent protein kinases inhibitors.

More on this story

Americas
28 January 2019   German pharmaceutical company Merck Group has granted US biotech firm Vertex a licence to two DNA-dependent protein kinases inhibitors.